Innate factors in human breast milk inhibit cell-free HIV-1 but not cell-associated HIV-1 infection of CD4+ cells

Journal of Acquired Immune Deficiency Syndromes

Volumn 51, Issue 2, 2009, Pages 117-124

  Lyimo, Magdalena A ^a   Howell, Alexandra L ^a,b   Balandya, Emmanuel ^a   Eszterhas, Susan K ^a,b   Connor, Ruth I ^a,c  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b VA MEDICAL CENTER   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Breast milk; CD4+ T lymphocytes; Cell associated HIV; Cell free HIVHIV

Indexed keywords

ANTIGEN P24; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GAG PROTEIN;

ARTICLE; BREAST MILK; CD4+ T LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIFE CYCLE ASSESSMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION; VIRUS DNA CELL DNA INTERACTION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; CELL FREE SYSTEM; CELL LINE; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; TIME; VIROLOGY;

CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL-FREE SYSTEM; GENE EXPRESSION REGULATION, VIRAL; HIV CORE PROTEIN P24; HIV-1; HUMANS; MILK, HUMAN; TIME FACTORS; VIRUS INTEGRATION;

EID: 67649220724     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181a3908d     Document Type: Article

References (46)

1. WHO. HIV Transmission Through Breast Feeding: A Review of Available Evidence. Geneva, Switzerland: UNAIDS WHO UNICEF UNFPA; 2004.
2. Fowler MG, Lampe MA, Jamieson DJ, et al. Reducing the risk of motherto-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions [review]. Am J Obstet Gynecol. 2007;197 (3 suppl):S3-S9.
3. Kourtis AP, Jamieson DJ, de Vincenzi I, et al. Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments [review]. Am J Obstet Gynecol. 2007;197 (3 suppl):S113-S122.
4. John-Stewart G, Mbori-Ngacha D, Ekpini R, et al; Ghent IAS Working Group on HIV in Women Children. Breast-feeding and transmission of HIV-1 [review]. J Acquir Immune Defic Syndr. 2004;35:196-202.
5. Coovadia HM, Rollins NC, Bland RM, et al. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet. 2007;369:1107-1116.
6. Nduati R, John G, Mbori-Ngacha D, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA. 2000;283:1167-1174.
7. Coutsoudis A. Influence of infant feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa. Ann N Y Acad Sci. 2000;918:136-144.
8. Coutsoudis A, Pillay K, Kuhn L, et al. South African Vitamin A Study Group. Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa. AIDS. 2001;15:379-387.
9. Iliff PJ, Piwoz EG, Tavengwa NV, et al. ZVITAMBO study group. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS. 2005; 19:699-708.
10. Baroncelli S, Andreotti M, Guidotti G, et al. Tumor necrosis factor-alpha, interleukin-10, and alpha-defensins in plasma and breast milk of HIV-infected highly active antiretroviral therapy-treated and untreated pregnant women in Mozambique. J Acquir Immune Defic Syndr. 2008;47: 647-649.
11. Bosire R, Guthrie BL, Lohman-Payne B, et al. Longitudinal comparison of chemokines in breastmilk early postpartum among HIV-1-infected and uninfected Kenyan women. Breastfeed Med. 2007;2:129-138.
12. Farquhar C, Mbori-Ngacha DA, Redman MW, et al. CC and CXC chemokines in breastmilk are associated with mother-to-child HIV-1 transmission. Curr HIV Res. 2005;3:361-369.
13. Duprat C, Mohammed Z, Datta P, et al. Human immunodeficiency virus type 1 IgA antibody in breast milk and serum. Pediatr Infect Dis J. 1994; 13:603-608.
14. Kuhn L, Trabattoni D, Kankasa C, et al. HIV-specific secretory IgA in breast milk of HIV-positive mothers is not associated with protection against HIV transmission among breast-fed infants. J Pediatr. 2006;149: 611-616.
15. Becquart P, Hocini H, Lévy M, et al. Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV. J Infect Dis. 2000;181:532-539.
16. Bosire R, John-Stewart GC, Mabuka JM, et al. Breast milk alphadefensins are associated with HIV type 1 RNA and CC chemokines in breast milk but not vertical HIV type 1 transmission. AIDS Res Hum Retroviruses. 2007;23:198-203.
17. Hoffman IF, Martinson FE, Stewart PW, et al. Human immunodeficiency virus type 1 RNA in breast-milk components. J Infect Dis. 2003;188: 1209-1212.
18. Pillay K, Coutsoudis A, York D, et al. Cell-free virus in breast milk of HIV-1-seropositive women. J Acquir Immune Defic Syndr. 2000;24: 330-336.
19. Lewis P, Nduati R, Kreiss JK, et al. Cell-free human immunodeficiency virus type 1 in breast milk. J Infect Dis. 1998;177:34-39.
20. Rousseau CM, Nduati RW, Richardson BA, et al. Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease. J Infect Dis. 2003; 187:741-747.
21. Rousseau CM, Nduati RW, Richardson BA, et al. Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. J Infect Dis. 2004;190:1880-1888.
22. Koulinska IN, Villamor E, Chaplin B, et al. Transmission of cell-free and cell-associated HIV-1 through breast-feeding. J Acquir Immune Defic Syndr. 2006;41:93-99.
23. Van de Perre P, Simonon A, Hitimana DG, et al. Infective and antiinfective properties of breastmilk from HIV-1-infected women. Lancet. 1993;341:914-918.
24. Kantarci S, Koulinska IN, Aboud S, et al. Subclinical mastitis, cellassociated HIV-1 shedding in breast milk, and breast-feeding transmission of HIV-1. J Acquir Immune Defic Syndr. 2007;46:651-654.
25. Southern SO. Milk-borne transmission of HIV Characterization of productively infected cells in breast milk and interactions between milk and saliva. J Hum Virol. 1998;1:328-337.
26. Petitjean G, Becquart P, Tuaillon E, et al. Isolation and characterization of HIV-1-infected resting CD4+ T lymphocytes in breast milk. J Clin Virol. 2007;39:1-8.
27. Kourtis AP, Ibegbu CC, Theiler R, et al. Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy. J Infect Dis. 2007;195:965-972.
28. Becquart P, Petitjean G, Tabaa YA, et al. Detection of a large T-cell reservoir able to replicate HIV-1 actively in breast milk. AIDS. 2006;20: 1453-1455.
29. Shapiro RL, Ndung'u T, Lockman S, et al. Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk. J Infect Dis. 2005;192:713-719.
30. Lehman DA, Chung MH, John-Stewart GC, et al. HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission. AIDS. 2008;22:1475-1485.
31. Mofenson LM. Antiretroviral prophylaxis to reduce breast milk transmission of HIV type 1: new data but still questions [review]. J Acquir Immune Defic Syndr. 2008;48:237-240.
32. Masuda T, Planelles V, Krogstad P, et al. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain. J Virol. 1995;69: 6687-6696.
33. Asin S, Bren GD, Carmona EM, et al. NF-kappa B cis-acting motifs of the human immunodeficiency virus (HIV) long terminal repeat regulate HIV transcription in human macrophages. J Virol. 2001;75:11408-11416.
34. Brussel A, Delelis O, Sonigo P. Alu-LTR real-time nested PCR assay for quantifying integrated HIV-1 DNA. Methods Mol Biol. 2005;304: 139-154.
35. Brooks DG, Hamer DH, Arlen PA, et al. Molecular characterization, reactivation, and depletion of latent HIV. Immunity. 2003;19:413-423.
36. Bouhlal H, Latry V, Requena M, et al. Natural antibodies to CCR5 from breast milk block infection of macrophages and dendritic cells with primary R5-tropic HIV-1. J Immunol. 2005;174:7202-7209.
37. Legrand D, Pierce A, Elass E, et al. Lactoferrin structure and functions [review]. Adv Exp Med Biol. 2008;606:163-194.
38. Garofalo RP, Goldman AS. Cytokines, chemokines, and colonystimulating factors in human milk: the 1997 update [review]. Biol Neonate. 1998;74:134-142.
39. Sabbaj S, Ghosh MK, Edwards BH, et al. Breast milk-derived antigenspecific CD8+ T cells: an extralymphoid effector memory cell population in humans. J Immunol. 2005;174:2951-2956.
40. Lohman BL, Slyker J, Mbori-Ngacha D, et al. Prevalence and magnitude of human immunodeficiency virus (HIV) type 1-specific lymphocyte responses in breast milk from HIV-1-seropositive women. J Infect Dis. 2003;188:1666-1674.
41. Viveros-Rogel M, Soto-Ramirez L, Chaturvedi P, et al. Inhibition of HIV-1 infection in vitro by human milk sulfated glycolipids and glycosaminoglycans. Adv Exp Med Biol. 2004;554:481-487.
42. Habte HH, Kotwal GJ, Lotz ZE, et al. Antiviral activity of purified human breast milk mucin. Neonatology. 2007;92:96-104.
43. Habte HH, de Beer C, Lotz ZE, et al. Inhibition of human immunodeficiency virus type 1 activity by purified human breast milk mucin (MUC1) in an inhibition assay. Neonatology. 2008;93:162-170.
44. Villamor E, Koulinska IN, Furtado J, et al. Long-chain n-6 polyunsaturated fatty acids in breast milk decrease the risk of HIV transmission through breastfeeding. Am J Clin Nutr. 2007;86:682-689.
45. Alfsen A, Yu H, Magérus-Chatinet A, et al. HIV-1-infected blood mononuclear cells form an integrin- and agrin-dependent viral synapse to induce efficient HIV-1 transcytosis across epithelial cell monolayer. Mol Biol Cell. 2005;16:4267-4279.
46. Yamaguchi K, Sugiyama T, Takizawa M, et al. Viability of infectious viral particles of HIV and BMCs in breast milk. J Clin Virol. 2007;39:222-225.